Click here for slides on this topic


C-reactive protein (CRP)

A protein found in the blood; levels of this protein rise in response to inflammation. Although inflammation is a normal response to many physical states, its presence plays a role in the initiation and progression of cardiovascular disease (CVD).


The following content matched the glossary term: C-reactive protein (CRP)

NDEI.org Expert Commentary on the JUPITER trial Peter Libby

Top

Peter Libby, MD, provides expert commentary on a new analysis from the JUPITER trial examining whether the benefits of statin use outweigh diabetes risk in primary prevention low-risk patients

JUPITER: Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-reactive Protein

Top

Ridker PM, Danielson E, Fonseca FA, et al; for the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359(21):2195-2207. The Justification for Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) was a randomized, double-blind, placebo-controlled trial which sought to examine whether rosuvastatin treatment compared with placebo would decrease the rate of first cardiovascular (CV) events.

JUPITER Analysis: Do Statin Benefits Outweigh Diabetes Risk?

Top

Exclusive! Expert commentary from Peter Libby, MD, on this analysis of the JUPITER trial. Ridker PM, Pradhan A, MacFadyen JG, Libby P, Glynn RJ. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet. 2012;380(9841):565-571.

American Diabetes Association 72nd Scientific Sessions Daily Coverage June 11, 2012

Top

Daily coverage of American Diabetes Association 72nd Scientific Sessions  June 11, 2012

ORIGIN trial results, insulin and cancer, TINSAL-T2D results, and more.

NDEI.org Expert Commentary Statins and Gender Peter Ganz

Top

Expert commentary on statins and gender from Peter Ganz, MD.

Clinical Insights in Cardiovascular Disease Volume 1 Issue 1 March 2012

Top

Clinical Insights® in Cardiovascular Disease newsletter featuring clinically relevant data and information on cardiovascular diseases and related conditions, including diabetes, dyslipidemia, hypertension, stroke, inflammation, and obesity.

Clinical Insights in Diabetes Newsletter Archive

Top

Clinical Insights® in Diabetes Newsletter Archive

NDEI.org Expert Commentary Mayer Davidson Liraglutide and CVD Risk

Top

Expert Commentary Mayer Davidson Liraglutide and CVD Risk

Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors

Top

Varanasi A, Patel P, Makdissi A, Dhindsa S, Chaudhuri A, Dandona P. Clinical use of liraglutide in type 2 diabetes and its effects on cardiovascular risk factors. Endocr Pract. 2011 Aug 19 1-13. Epub ahead of print. This study assessed the effect of liraglutide on cardiovascular disease risk factors, and is the first report on liraglutide in combination with insulin.

Supervised exercise training counterbalances the adverse effects of insulin therapy in overweight/obese subjects with type 2 diabetes

Top

Balducci S, Zanuso S, Cardelli P, Salerno G, Fallucca S, Nicolucci A, Pugliese G; for the Italian Diabetes Exercise Study (IDES) Investigators. Supervised exercise training counterbalances the adverse effects of insulin therapy in overweight/obese subjects with type 2 diabetes. Diabetes Care. 2011 Oct 19. [Epub ahead of print]. To examine the effect of supervised exercise on traditional and nontraditional cardiovascular risk factors in sedentary, overweight/obese insulin-treated subjects with type 2 diabetes from the Italian Diabetes Exercise Study.

1 2 3 4 5 6 7 Next 

Slide Library Results

Search Results for: C-reactive protein (CRP) Slides Found: 3
Adiponectin and CRP Levels in Healthy Obese Women
Effect of Diet and Exercise on Inflammatory Markers
Edinburgh Type 2 Diabetes Study Severe Hypoglycemia Slide PPT | NDEI